Provided by Tiger Trade Technology Pte. Ltd.

Nyxoah SA

3.59
+0.05001.41%
Post-market: 3.590.00000.00%16:17 EDT
Volume:28.14K
Turnover:99.02K
Market Cap:156.75M
PE:-1.37
High:3.59
Open:3.55
Low:3.45
Close:3.54
52wk High:11.87
52wk Low:3.39
Shares:43.66M
Float Shares:24.32M
Volume Ratio:0.76
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6289
EPS(LYR):-1.8730
ROE:-107.57%
ROA:-43.98%
PB:2.67
PE(LYR):-1.92

Loading ...

Company Profile

Company Name:
Nyxoah SA
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
184
Office Location:
Rue Edouard Belin 12,Mont-Saint-Guibert,Walloon Brabant,Belgium
Zip Code:
1435
Fax:
32 1 045 90 75
Introduction:
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Directors

Name
Position
Olivier Taelman
Executive Director,Chief Executive Officer
Robert Taub
Non-Executive Director,Chairman of the Board
Donald Deyo
Non-Executive Director
Jan Janssen
Non-Executive Director
Janke Dittmer
Non-Executive Director
Jurgen Hambrecht
Non-Executive Director
Kevin Rakin
Non-Executive Director
Pierre Gianello
Non-Executive Director

Shareholders

Name
Position
Olivier Taelman
Executive Director,Chief Executive Officer
Fabian Suarez Gonzalez
Chief Financial Officer